Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. - Wikidata - wikimedia - TriplyDB

Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.

Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.

http://www.wikidata.org/entity/Q37279801

about

Pharmacological interventions for the treatment of delirium in critically ill patients Neurocognitive dysfunction risk alleviation with the use of dexmedetomidine in perioperative conditions or as ICU sedation: a meta-analysis Pharmacological and nonpharmacological management of delirium in critically ill patients.Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials Spatiotemporal Dynamics of Dexmedetomidine-Induced Electroencephalogram Oscillations Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis Dexmedetomidine in the treatment of serotonin syndrome.Haloperidol prophylaxis in critically ill patients with a high risk for delirium Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.Nicotine withdrawal and agitation in ventilated critically ill patients.Beneficial effects of loxapine on agitation and breathing patterns during weaning from mechanical ventilation.Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery.Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions.Pharmacological interventions for delirium in intensive care patients: a protocol for an overview of reviews Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU Sedation with dexmedetomidine in the intensive care setting.Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients.Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in non-intubated patients Risk factors for agitation in critically ill patients.An updated focused review of dexmedetomidine in adults.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.Smoking Cessation and the Risk of Hyperactive Delirium in Hospitalized Patients: A Retrospective Study.Sedation of mechanically ventilated adults in intensive care unit: a network meta-analysis.Review article: dexmedetomidine: does it have potential in palliative medicine?Role of α2-agonists in the treatment of acute alcohol withdrawal.Sedation and analgesia in the mechanically ventilated patient.Haloperidol dosing strategies in the treatment of delirium in the critically ill.Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management.A case-based approach to the practical application of dexmedetomidine in critically ill adults.Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients.Pain management in neurocritical care.Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research.Intensive care unit delirium: a review of the literature.Glomerular haemodynamics, the renal sympathetic nervous system and sepsis-induced acute kidney injury.Comparison of propofol and dexmedetomidine infused overnight to treat hyperactive and mixed ICU delirium: a protocol for the Basel ProDex clinical trial.A new approach to the prevention and treatment of delirium in elderly patients in the intensive care unit.Pharmacologic and nonpharmacologic approaches to the prevention and management of delirium.Preventive strategies and potential therapeutic interventions for delirium in sepsis.

P2860

Q24187548-AA3800EC-4E8D-4712-89F0-9C11D10008F0 Q26992179-10918FB8-B644-4224-AB96-F03358F73357 Q27005223-31D42FF1-DAC1-40B9-9CE3-C014B4722222 Q28263230-B6B34C8F-96C6-4096-BA03-620BD628731A Q28305234-EFC1F99B-635C-4C3F-951A-9E5B064E5DAA Q28554554-5B6A9BAE-81FE-4723-9F7C-167914E89866 Q28821103-2CF82FA4-92FF-4ADC-AFBD-ABAD57A39508 Q30458981-C735612B-827E-4DE9-A670-62AF8034E506 Q33750794-D865400E-CBA9-4EB8-83CF-DD83AC60C5B9 Q33844380-9FA10D62-F12C-4600-B664-761F9A27837F Q33919223-8250DAD7-2C20-44B7-BC26-96FF04823C83 Q34026829-A41C2FFB-3A7A-4617-9172-2A8D4F789582 Q35483280-8B912421-5007-4A6D-863E-967694F6A150 Q36052226-027DB113-C53A-4929-8787-376CC794EFCF Q36214472-9F1271AF-5854-4E78-BB11-BE88D6E908B9 Q36297368-8B91168C-3F25-4E58-9ACB-D4ACF0650E23 Q36581314-2582F915-CEAA-4153-8046-18578ABD976A Q36705796-8F10A971-33DE-45C4-963B-46ECB0EAFBBD Q37092640-BC23978B-FFDA-42CE-AC92-65B296D58F06 Q37121469-63ECBE94-C045-49F7-A01D-AF6793F51E2B Q37579543-19CA0A08-E6D8-457C-9B64-53618E49CCF5 Q37637755-46E11D82-A214-4B26-93DE-194998B118D0 Q37686927-0F98DDD2-720A-476A-9467-CD91E19A7DD5 Q37696747-91FE33CE-FBC0-4A8B-82CB-B1103C21232D Q37712976-F3139BE8-4E26-4E72-8593-84811BDA7164 Q37816062-C88C3CC7-6508-42A6-B64D-BC3423EA3754 Q37869277-5F52A915-3C5A-453C-BDCC-742AC8870361 Q37948029-7748FC9C-35BD-4AB4-B9DC-62DB1EF7A664 Q37950933-1228D800-87C4-4366-B768-A877F633C238 Q38026952-5699BBE7-90B7-4022-8BCF-7583A82A3518 Q38079560-70688FF5-B270-455F-9D5C-F54513BB1E0A Q38110444-374221E8-A511-4ECA-BAD8-C32A69EECA4A Q38124745-5FCA7B8B-FDD7-41CB-8686-E3A86D3B44D4 Q38131455-FC4D8ED1-62BA-41EB-AF16-A4197F1858E4 Q38170237-A24BEAC0-D82D-4F41-A56E-6E76E36ADF06 Q38195194-9D49FF0C-A0EC-45FB-98F2-052F3448E65B Q38373143-28576F44-3218-42E5-B8F8-8DF7ED9787E2 Q38579446-343ECAFF-184E-4FAA-89FD-21DAA3878C06 Q38760118-5408961D-EBA4-4EBE-A432-B961BCF08C3A Q38862634-F7A96C35-D93B-4800-8148-3B4478B24912

P2860

Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.

http://www.wikidata.org/entity/Q37279801

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@en

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@nl

type

label

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@en

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@nl

prefLabel

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@en

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@nl

P1433

Q37279801-8772F0CF-2364-4E45-8600-6DD5E8E76FCA

P1476

Q37279801-9B9C573D-AFE6-48AE-8BE9-D387758A391A

P2093

Q37279801-4078A0F0-D497-463A-83EF-9B2AD6187BE5

Q37279801-6FDF4F3E-DFBF-4DEE-AD7D-D7D67EEC1DFE

Q37279801-AEB8D05F-763A-4A3B-922C-F8A57A54C3FD

Q37279801-B5788529-65C5-4C69-BC00-2AD2BC24DD4D

Q37279801-B5FA2FE4-C301-462D-9F80-9C2950089973

P2860

Q37279801-04341DAA-C339-4E2E-B4E4-C3D7C21BC9EF

Q37279801-050936F4-AE30-4A79-8384-CDB3ED6ED448

Q37279801-096C078B-0DE8-4ED3-B8D0-BE12BC7B5B55

Q37279801-0A9039B3-22C1-46D4-8D12-5AC30C3D7A1A

Q37279801-1CD54870-7DE2-477E-9B4F-F73F3458B71B

Q37279801-32ED331E-BB0C-4F36-A7E8-687D1DBD59B9

Q37279801-38714EDB-85E6-4794-A87D-8503881BEE86

Q37279801-43D07F27-27C0-40FB-85E8-498BD4227013

Q37279801-6C8C999F-C2BF-49EC-AA1D-033BA86C64E5

Q37279801-6CAF1A54-6B83-44BD-ACB2-4903530194D2

P2888

Q37279801-E8EA491A-6941-41C4-A1B6-8DFF0EF4E316

P304

Q37279801-EC9AB1C6-210C-40A6-9867-363E978C4514

P31

Q37279801-03888BDB-C5D0-4A21-A3CE-05CB28A36B6C

P356

Q37279801-DD568360-BB7C-4D9A-B8CA-2BBE3FED8B4B

P433

Q37279801-54B6BAAB-763A-406F-A461-3419855EB34B

P478

Q37279801-7E7FA668-8147-4514-B2EA-290B2F4743D8

P50

Q37279801-66A26550-CC87-4BC4-8660-FD5688CAF16D

P577

Q37279801-9D315434-B9A8-48DB-AD27-657A76B2F914

P5875

Q37279801-9CA3F2C5-E34B-4E6E-9A0A-86CB118837CD

P6179

Q37279801-85532213-4ACA-48BF-B432-25CD54820E42

P698

Q37279801-A5EECE39-C74E-4A2C-A31C-B198FB517C6A

P921

Q37279801-49C4F461-3F2D-4AF9-B623-8E967F8ECC84

P932

Q37279801-42F54809-A7EB-4851-8FB0-5BDD920982A0

P356

P1433

P1476

Dexmedetomidine vs. haloperido ...... a randomised open-label trial.

@en

P2093

Donna Goldsmith

http://www.w3.org/2001/XMLSchema#string

Kim O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Michael C Reade

http://www.w3.org/2001/XMLSchema#string

Samantha Bates

http://www.w3.org/2001/XMLSchema#string

William R S T J Ainslie

http://www.w3.org/2001/XMLSchema#string

P2860

Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects

Subsyndromal delirium in the ICU: evidence for a disease spectrum

Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

Intensive Care Delirium Screening Checklist: evaluation of a new screening tool.

Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU).

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.

Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.

Antipsychotics in the treatment of delirium: a systematic review.

P2888

P304

R75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC7890

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Rinaldo Bellomo

P577

2009-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24438758

http://www.w3.org/2001/XMLSchema#string

P6179

1004287775

http://www.w3.org/2001/XMLSchema#string

P698

19454032

http://www.w3.org/2001/XMLSchema#string

P921

P932

2717438

http://www.w3.org/2001/XMLSchema#string